These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16227233)

  • 21. Soluble gC1q-R/p33, a cell protein that binds to the globular "heads" of C1q, effectively inhibits the growth of HIV-1 strains in cell cultures.
    Szabó J; Cervenák L; Tóth FD; Prohászka Z; Horváth L; Kerekes K; Beck Z; Bácsi A; Erdei A; Peerschke EI; Füst G; Ghebrehiwet B
    Clin Immunol; 2001 May; 99(2):222-31. PubMed ID: 11318594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Full-length human surfactant protein A inhibits influenza A virus infection of A549 lung epithelial cells: A recombinant form containing neck and lectin domains promotes infectivity.
    Al-Qahtani AA; Murugaiah V; Bashir HA; Pathan AA; Abozaid SM; Makarov E; Nal-Rogier B; Kishore U; Al-Ahdal MN
    Immunobiology; 2019 May; 224(3):408-418. PubMed ID: 30954271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Restricted HIV-1 Env glycan engagement by lectin-reengineered DAVEI protein chimera is sufficient for lytic inactivation of the virus.
    Parajuli B; Acharya K; Bach HC; Parajuli B; Zhang S; Smith AB; Abrams CF; Chaiken I
    Biochem J; 2018 Mar; 475(5):931-957. PubMed ID: 29343613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Salivary agglutinin inhibits HIV type 1 infectivity through interaction with viral glycoprotein 120.
    Wu Z; Van Ryk D; Davis C; Abrams WR; Chaiken I; Magnani J; Malamud D
    AIDS Res Hum Retroviruses; 2003 Mar; 19(3):201-9. PubMed ID: 12689412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced influenza viral neutralizing activity of natural human trimers of surfactant protein D.
    Hartshorn KL; White MR; Tecle T; Tornoe I; Sorensen GL; Crouch EC; Holmskov U
    Respir Res; 2007 Feb; 8(1):9. PubMed ID: 17280604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus Macaques.
    Jones AT; Chamcha V; Kesavardhana S; Shen X; Beaumont D; Das R; Wyatt LS; LaBranche CC; Stanfield-Oakley S; Ferrari G; Montefiori DC; Moss B; Tomaras GD; Varadarajan R; Amara RR
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29237847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human pulmonary surfactant protein D binds the extracellular domains of Toll-like receptors 2 and 4 through the carbohydrate recognition domain by a mechanism different from its binding to phosphatidylinositol and lipopolysaccharide.
    Ohya M; Nishitani C; Sano H; Yamada C; Mitsuzawa H; Shimizu T; Saito T; Smith K; Crouch E; Kuroki Y
    Biochemistry; 2006 Jul; 45(28):8657-64. PubMed ID: 16834340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of the optimal DC-SIGN binding site on human immunodeficiency virus type 1 gp120.
    Hong PW; Nguyen S; Young S; Su SV; Lee B
    J Virol; 2007 Aug; 81(15):8325-36. PubMed ID: 17522223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein-Protein Interaction between Surfactant Protein D and DC-SIGN
    Dodagatta-Marri E; Mitchell DA; Pandit H; Sonawani A; Murugaiah V; Idicula-Thomas S; Nal B; Al-Mozaini MM; Kaur A; Madan T; Kishore U
    Front Immunol; 2017; 8():834. PubMed ID: 28824609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carbohydrate-binding agents cause deletions of highly conserved glycosylation sites in HIV GP120: a new therapeutic concept to hit the achilles heel of HIV.
    Balzarini J; Van Laethem K; Hatse S; Froeyen M; Peumans W; Van Damme E; Schols D
    J Biol Chem; 2005 Dec; 280(49):41005-14. PubMed ID: 16183648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glycosylation patterns of HIV-1 gp120 depend on the type of expressing cells and affect antibody recognition.
    Raska M; Takahashi K; Czernekova L; Zachova K; Hall S; Moldoveanu Z; Elliott MC; Wilson L; Brown R; Jancova D; Barnes S; Vrbkova J; Tomana M; Smith PD; Mestecky J; Renfrow MB; Novak J
    J Biol Chem; 2010 Jul; 285(27):20860-9. PubMed ID: 20439465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequence and expression of a membrane-associated C-type lectin that exhibits CD4-independent binding of human immunodeficiency virus envelope glycoprotein gp120.
    Curtis BM; Scharnowske S; Watson AJ
    Proc Natl Acad Sci U S A; 1992 Sep; 89(17):8356-60. PubMed ID: 1518869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycan deletions in the HIV-1 gp120 V1/V2 domain compromise viral infectivity, sensitize the mutant virus strains to carbohydrate-binding agents and represent a specific target for therapeutic intervention.
    Auwerx J; François KO; Covens K; Van Laethem K; Balzarini J
    Virology; 2008 Dec; 382(1):10-9. PubMed ID: 18930512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of small-molecule human immunodeficiency virus type 1 entry inhibitors that target the gp120-binding domain of CD4.
    Yang QE; Stephen AG; Adelsberger JW; Roberts PE; Zhu W; Currens MJ; Feng Y; Crise BJ; Gorelick RJ; Rein AR; Fisher RJ; Shoemaker RH; Sei S
    J Virol; 2005 May; 79(10):6122-33. PubMed ID: 15857997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-linked glycosylation of the V3 loop and the immunologically silent face of gp120 protects human immunodeficiency virus type 1 SF162 from neutralization by anti-gp120 and anti-gp41 antibodies.
    McCaffrey RA; Saunders C; Hensel M; Stamatatos L
    J Virol; 2004 Apr; 78(7):3279-95. PubMed ID: 15016849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Structure and function of oligosaccharide chains of the envelope glycoprotein gp120 of human immunodeficiency virus type 1].
    Mizuochi T
    Nihon Rinsho; 1992 Jun; 50(6):1419-29. PubMed ID: 1518160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of macrophage mannose receptor in the binding and transmission of HIV by macrophages.
    Nguyen DG; Hildreth JE
    Eur J Immunol; 2003 Feb; 33(2):483-93. PubMed ID: 12645947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effective targeting of pathogens to neutrophils via chimeric surfactant protein D/anti-CD89 protein.
    Tacken PJ; Hartshorn KL; White MR; van Kooten C; van de Winkel JG; Reid KB; Batenburg JJ
    J Immunol; 2004 Apr; 172(8):4934-40. PubMed ID: 15067073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-Mannose Specific Lectin and Its Recombinants from a Carrageenophyta Kappaphycus alvarezii Represent a Potent Anti-HIV Activity Through High-Affinity Binding to the Viral Envelope Glycoprotein gp120.
    Hirayama M; Shibata H; Imamura K; Sakaguchi T; Hori K
    Mar Biotechnol (NY); 2016 Apr; 18(2):215-31. PubMed ID: 26661793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA vaccine molecular adjuvants SP-D-BAFF and SP-D-APRIL enhance anti-gp120 immune response and increase HIV-1 neutralizing antibody titers.
    Gupta S; Clark ES; Termini JM; Boucher J; Kanagavelu S; LeBranche CC; Abraham S; Montefiori DC; Khan WN; Stone GW
    J Virol; 2015 Apr; 89(8):4158-69. PubMed ID: 25631080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.